Protective activity of Mildronate, Dalargin and Picamilon in experimental stress
T. I. Frantsuzova · 2011 · Candidate dissertation, Saransk, 2011; 129 pages
What does this source report?
The dissertation examines three separate pharmacological approaches to experimental stress, including behavior, gastric injury and nonspecific cellular immunity. The comparative program connects opioid-peptide research with Picamilon and Mildronate.
- Population and setting
- Experimental animal stress models
- Evidence type
- Animal / experimental
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Selected transcription reviewed; full tables and statistical appraisal remain pending.
- Head-to-head comparison is not evidence of a three-drug combination or human stress treatment.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Review depth: Selected text reviewed
Source access and review scope
Selected source text and metadata checked; full risk-of-bias review pending.
Recorded source-check date: 2026-10-04. This date does not imply a completed systematic review.
Cite and trace this record
Original source: T. I. Frantsuzova. Protective activity of Mildronate, Dalargin and Picamilon in experimental stress Candidate dissertation, Saransk, 2011; 129 pages 2011.
Molekul research summary: https://molekul.io/research/dalargin-stress-frantsuzova-2011. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entryRelated compound profiles
Dalargin
A Soviet synthetic opioid hexapeptide investigated in cytoprotection, stress, hypoxia, ischemia and trauma. Its enkephalin lineage is distinct from organ-derived peptide bioregulators; historical proposals and laboratory effects are not established clinical indications.
Picamilon
A synthetic nicotinoyl-GABA compound connecting Soviet cerebrovascular pharmacology with later swimmer, clinical and occupational research. Shustov lists it as an alternative in a proposed mental-work framework; no Picamilon shipboard trial is established here.